Credit Suisse Ag Biocryst Pharmaceuticals Inc Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Credit Suisse Ag holds 229,544 shares of BCRX stock, worth $1.69 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

229,544

Previous 229,544 -0.0%

Holding current value

$1.69 Million

Previous $1.37 Million 15.14%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$4.98 - $6.77 $7,504 - $10,202	-1,507 Reduced 0.65%	229,544 $1.37 Million
Q3 2023 Nov 13, 2023	SELL	$6.71 - $7.92 $341,981 - $403,650	-50,966 Reduced 18.07%	231,051 $1.64 Million
Q2 2023 Aug 11, 2023	BUY	$6.96 - $8.81 $146,048 - $184,869	20,984 Added 8.04%	282,017 $1.99 Million
Q1 2023 May 10, 2023	BUY	$7.94 - $11.84 $69,729 - $103,978	8,782 Added 3.48%	261,033 $2.18 Million
Q4 2022 Feb 13, 2023	BUY	$10.5 - $14.2 $28,801 - $38,950	2,743 Added 1.1%	252,251 $2.9 Million
Q3 2022 Nov 10, 2022	BUY	$10.79 - $14.81 $27,730 - $38,061	2,570 Added 1.04%	249,508 $3.14 Million
Q2 2022 Aug 12, 2022	SELL	$7.89 - $17.88 $85,614 - $194,015	-10,851 Reduced 4.21%	246,938 $2.61 Million
Q1 2022 May 16, 2022	BUY	$11.56 - $19.76 $160,464 - $274,288	13,881 Added 5.69%	257,789 $4.19 Million
Q4 2021 Feb 14, 2022	SELL	$11.18 - $15.46 $5.63 Million - $7.78 Million	-503,137 Reduced 67.35%	243,908 $3.38 Million
Q3 2021 Nov 12, 2021	BUY	$14.21 - $17.65 $440,737 - $547,432	31,016 Added 4.33%	747,045 $10.7 Million
Q2 2021 Aug 16, 2021	BUY	$9.5 - $17.24 $4.56 Million - $8.27 Million	479,982 Added 203.34%	716,029 $11.3 Million
Q1 2021 May 14, 2021	SELL	$7.37 - $13.61 $1.25 Million - $2.31 Million	-169,719 Reduced 41.83%	236,047 $2.4 Million
Q4 2020 Feb 12, 2021	SELL	$3.37 - $8.61 $2.95 Million - $7.55 Million	-876,380 Reduced 68.35%	405,766 $3.02 Million
Q3 2020 Nov 13, 2020	BUY	$3.43 - $5.53 $1.77 Million - $2.85 Million	515,059 Added 67.14%	1,282,146 $4.4 Million
Q2 2020 Aug 12, 2020	SELL	$1.9 - $5.61 $203,877 - $601,975	-107,304 Reduced 12.27%	767,087 $3.66 Million
Q1 2020 May 13, 2020	SELL	$1.6 - $4.11 $1.16 Million - $2.99 Million	-727,924 Reduced 45.43%	874,391 $1.75 Million
Q4 2019 Feb 12, 2020	BUY	$1.59 - $3.45 $685,092 - $1.49 Million	430,876 Added 36.78%	1,602,315 $5.53 Million
Q3 2019 Nov 12, 2019	BUY	$2.5 - $3.73 $2.56 Million - $3.82 Million	1,023,363 Added 691.11%	1,171,439 $3.36 Million
Q2 2019 Aug 14, 2019	SELL	$2.91 - $9.15 $66,583 - $209,361	-22,881 Reduced 13.38%	148,076 $560,000
Q1 2019 May 14, 2019	BUY	$7.38 - $9.72 $526,651 - $693,638	71,362 Added 71.65%	170,957 $1.39 Million
Q4 2018 Feb 13, 2019	BUY	$6.51 - $9.6 $395,808 - $583,680	60,800 Added 156.72%	99,595 $804,000
Q3 2018 Nov 13, 2018	SELL	$5.52 - $7.99 $130,393 - $188,739	-23,622 Reduced 37.85%	38,795 $296,000
Q2 2018 Aug 14, 2018	SELL	$4.6 - $6.52 $108,546 - $153,852	-23,597 Reduced 27.43%	62,417 $358,000
Q1 2018 May 15, 2018	BUY	$4.35 - $5.82 $71,531 - $95,704	16,444 Added 23.64%	86,014 $411,000
Q4 2017 Feb 14, 2018	SELL	$4.16 - $5.33 $110,976 - $142,188	-26,677 Reduced 27.72%	69,570 $342,000
Q3 2017 Nov 14, 2017	SELL	$4.1 - $5.97 $41,291 - $60,123	-10,071 Reduced 9.47%	96,247 $505,000
Q2 2017 Aug 14, 2017	BUY	N/A	106,318	106,318 $590,000

Others Institutions Holding BCRX

# of Institutions

257

Shares Held

173M

Call Options Held

397K

Put Options Held

444K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.37B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account